Megan S. Ford

644 total citations
11 papers, 527 citations indexed

About

Megan S. Ford is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Megan S. Ford has authored 11 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Oncology and 2 papers in Surgery. Recurrent topics in Megan S. Ford's work include T-cell and B-cell Immunology (7 papers), Immune Cell Function and Interaction (5 papers) and CAR-T cell therapy research (3 papers). Megan S. Ford is often cited by papers focused on T-cell and B-cell Immunology (7 papers), Immune Cell Function and Interaction (5 papers) and CAR-T cell therapy research (3 papers). Megan S. Ford collaborates with scholars based in Canada, United Kingdom and Belgium. Megan S. Ford's co-authors include Wenhao Chen, Kevin J. Young, Li Zhang, Pamela S. Ohashi, Zhu‐Xu Zhang, Mary C. Verrier, Jefferson R. Wilson, Brian Drew, Amresh Kumar Singh and B. Catharine Craven and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and European Journal of Immunology.

In The Last Decade

Megan S. Ford

10 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Megan S. Ford Canada 8 327 159 148 73 61 11 527
TH. JOOST Netherlands 11 156 0.5× 43 0.3× 145 1.0× 53 0.7× 40 0.7× 15 533
J. Lou Switzerland 9 140 0.4× 78 0.5× 26 0.2× 51 0.7× 90 1.5× 15 374
Isabela Schmitt‐Knosalla Germany 6 409 1.3× 79 0.5× 21 0.1× 65 0.9× 26 0.4× 7 525
Rikhia Chakraborty United States 11 169 0.5× 126 0.8× 90 0.6× 133 1.8× 8 0.1× 22 524
Hector A. DePaz United States 10 237 0.7× 101 0.6× 43 0.3× 58 0.8× 10 0.2× 36 397
Bibiana Quirant‐Sánchez Spain 14 171 0.5× 35 0.2× 104 0.7× 53 0.7× 12 0.2× 36 392
Ioannis Kalampokis United States 5 280 0.9× 30 0.2× 76 0.5× 43 0.6× 9 0.1× 10 422
Jacquelyn M. Lykken United States 6 220 0.7× 32 0.2× 40 0.3× 78 1.1× 17 0.3× 20 351
Peter‐Paul A. Unger Netherlands 10 257 0.8× 31 0.2× 70 0.5× 75 1.0× 17 0.3× 17 378
Sharifah Nur Hazirah Singapore 9 107 0.3× 66 0.4× 37 0.3× 107 1.5× 39 0.6× 11 380

Countries citing papers authored by Megan S. Ford

Since Specialization
Citations

This map shows the geographic impact of Megan S. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan S. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan S. Ford more than expected).

Fields of papers citing papers by Megan S. Ford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan S. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan S. Ford. The network helps show where Megan S. Ford may publish in the future.

Co-authorship network of co-authors of Megan S. Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Megan S. Ford. A scholar is included among the top collaborators of Megan S. Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan S. Ford. Megan S. Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ford, Megan S., Paul Thomson, Adam Lister, et al.. (2025). Bioactivation of the β-Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor Atabecestat Leads to Protein Adduct Formation on Glutathione S-Transferase Pi. Chemical Research in Toxicology. 38(5). 812–815.
3.
Ford, Megan S., Paul Thomson, Jan Snoeys, Xiaoli Meng, & Dean J. Naisbitt. (2024). Selective HLA Class II Allele-Restricted Activation of Atabecestat Metabolite-Specific Human T-Cells. Chemical Research in Toxicology. 37(10). 1712–1727. 1 indexed citations
4.
Wilson, Jefferson R., Amresh Kumar Singh, B. Catharine Craven, et al.. (2012). Early versus late surgery for traumatic spinal cord injury: the results of a prospective Canadian cohort study. Spinal Cord. 50(11). 840–843. 152 indexed citations
5.
Ford, Megan S., Wenhao Chen, Sophie Y. Wong, et al.. (2007). Peptide‐activated double‐negative T cells can prevent autoimmune type‐1 diabetes development. European Journal of Immunology. 37(8). 2234–2241. 47 indexed citations
6.
Ford, Megan S., et al.. (2006). Double-Negative T Regulatory Cells Can Develop Outside the Thymus and Do Not Mature from CD8+ T Cell Precursors. The Journal of Immunology. 177(5). 2803–2809. 48 indexed citations
7.
Lee, Boris P.-L., Elaine Mansfield, Tina Hernandez‐Boussard, et al.. (2005). Expression Profiling of Murine Double-Negative Regulatory T Cells Suggest Mechanisms for Prolonged Cardiac Allograft Survival. The Journal of Immunology. 174(8). 4535–4544. 30 indexed citations
8.
Chen, Wenhao, Megan S. Ford, Kevin J. Young, & Li Zhang. (2004). The role and mechanisms of double negative regulatory T cells in the suppression of immune responses.. PubMed. 1(5). 328–35. 42 indexed citations
9.
Chen, Wenhao, Megan S. Ford, Kevin J. Young, Myron I. Cybulsky, & Zhang Li. (2003). Role of Double-Negative Regulatory T Cells in Long-Term Cardiac Xenograft Survival. The Journal of Immunology. 170(4). 1846–1853. 65 indexed citations
10.
Chen, Wenhao, et al.. (2003). Infusion of in vitro–generated DN T regulatory cells induces permanent cardiac allograft survival in mice. Transplantation Proceedings. 35(7). 2479–2480. 36 indexed citations
11.
Ford, Megan S., Kevin J. Young, Zhu‐Xu Zhang, Pamela S. Ohashi, & Li Zhang. (2002). The Immune Regulatory Function of Lymphoproliferative Double Negative T Cells In Vitro and In Vivo. The Journal of Experimental Medicine. 196(2). 261–267. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026